The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

Ngly1  -  N-glycanase 1

Mus musculus

Synonyms: 1110002C09Rik, PNGase, Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase, Peptide:N-glycanase, Png1, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ngly1

  • PNG1 encodes a soluble protein that, when expressed in Escherichia coli, exhibited PNGase activity [1].
  • To characterize the dual role of HR23, we have determined the high resolution crystal structure of the mouse peptide N-glycanase catalytic core in complex with the xeroderma pigmentosum group C binding domain from HR23B [2].
  • Treatment of 3H-labeled immunoprecipitated melanoma PAA with alkaline-borohydride, hydrazinolysis, or N-glycanase released three families of carbohydrate chains (I, II, and III) [3].
  • One of these, PNGase F, is a glycosidase specific for N-linked glycans, and the other, ST-Siase(2,3) from Salmonella typhimurium, is specific for alpha2,3-linked terminal sialic acid residues [4].
  • Treatment of synaptic membranes with proteinase K and Staphylococcus aureus V-8 proteinase, a combination of PNGase F and neuroaminidase, heat or acid lowered the 125I-ammodytoxin A specific binding to various extents but never completely abolished it [5].

High impact information on Ngly1

  • MAdCAM-1 isolated from mesenteric lymph nodes, but not from cultured endothelioma cells, bears N-glycanase-resistant sialic acid-containing carbohydrate which supports adhesion of L-selectin-transfected lymphoid cells under shear [6].
  • However, it is pronase sensitive and dependent on N-linked glycosylation of CD5, since treatment of CD5Rg with PNGaseF on N-glycanase completely abrogates its ability to bind activated splenocytes [7].
  • The amino acid substitutions and differences in the number of potential N-linked glycosylation sites probably account for the different forms of neutrophil FcR III observed after digestion with N-glycanase and for the antigenic heterogeneity of this receptor [8].
  • In this pathway the cytosolic peptide-N-glycanase (PNGase) cleaves the N-linked glycan chains off denatured glycoproteins [9].
  • In higher eukaryotes, PNGase has an N-terminal and a C-terminal extension in addition to its central catalytic domain, which is structurally and functionally related to transglutaminases [9].

Biological context of Ngly1


Anatomical context of Ngly1

  • A 2.6kb Ngly1 message was detected in all mouse tissues examined, with the highest abundance in the testis [10].
  • Peptide:N-glycanase (PNGase) is ostensibly the sole enzyme responsible for deglycosylation of unfolded N-linked glycoproteins dislocated from the ER to the cytosol [13].
  • These differ with respect to their apparent molecular masses after digestion with N-glycanase, and with respect to their reactivity with MAb Gran 11 and alloantisera which recognize determinants (NA1 and NA2) of the biallelic neutrophil antigen (NA) system [8].
  • This size difference was due to altered carbohydrate composition, as N-glycanase digestion reduced the apparent receptor subunit size of the transfected cells and IM-9 lymphocytes to identical values [14].
  • N-linked glycans, obtained from N-glycanase-treated IgD and purified by binding to GS-1-Sepharose, also inhibit rosette formation of T-helper cells bearing receptors for IgD with IgD- or mutant IgD-coated erythrocytes [15].

Associations of Ngly1 with chemical compounds

  • Remarkably, proteasome-mediated turnover of class I MHC heavy chains proceeds even when PNGase is completely inhibited, suggesting that the function of PNGase may be to facilitate more efficient proteasomal proteolysis of N-linked glycoproteins through glycan removal [13].
  • No reactions were observed with dp72 and lectins in Western blots; and neither tunicamycin, N-glycanase, endoglycosidase H nor F affected the migration of [35S]-methionine-labeled protein on SDS-PAGE [16].
  • Deglycosylation experiments with N-glycanase and endoglycosidase H indicated that the S-MBP ligands on thymic CD45 are high mannose type or hybrid type N-linked oligosaccharides [17].
  • The minimum structural requirements for inhibition of the PNGase activity were Man3 and GlcNAc2 [18].
  • Peptide N-glycanase features a large cleft between its catalytic cysteine protease core and zinc binding domain [2].

Other interactions of Ngly1

  • The higher m.w. form was glycosylated based on its sensitivity to n-glycanase and displayed a m.w. consistent with that of TNF-beta (LT) [19].
  • Serial partial deglycosylation of cross-linked NMB-Rs with PNGase F treatment for different incubation periods revealed one band of partially glycosylated receptor (53 kDa) besides the fully glycosylated and fully deglycosylated ones, showing that NMB-R has two oligosaccharide chains [20].
  • After the WGL eluates for the four species were treated with N-Glycanase, the labeled receptors became much sharper bands with very similar molecular masses, i.e., 43 kDa for the cow and guinea pig, 39 kDa for the rat, and and 40 kDa for the mouse.(ABSTRACT TRUNCATED AT 400 WORDS)[21]
  • Differential susceptibility to N-glycanase at the individual glycosylation sites of mouse thyrotropin and free alpha-subunits [22].
  • Enzymatic removal of preformed carbohydrate chains with N-glycanase had little or no effect on the MAb-reactivity of epitopes V and VII, indicating that the carbohydrate chains per se do not influence the antigenic specificity of VSV-NJ G protein [23].

Analytical, diagnostic and therapeutic context of Ngly1


  1. PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase. Suzuki, T., Park, H., Hollingsworth, N.M., Sternglanz, R., Lennarz, W.J. J. Cell Biol. (2000) [Pubmed]
  2. Structure of the Mouse Peptide N-Glycanase-HR23 Complex Suggests Co-evolution of the Endoplasmic Reticulum-associated Degradation and DNA Repair Pathways. Zhao, G., Zhou, X., Wang, L., Li, G., Kisker, C., Lennarz, W.J., Schindelin, H. J. Biol. Chem. (2006) [Pubmed]
  3. Glycosylation characteristics of pigmentation-associated antigen (GP75): an intracellular glycoprotein of human melanocytes and malignant melanomas. Roux, L., Lloyd, K.O. Arch. Biochem. Biophys. (1986) [Pubmed]
  4. CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes. Berger, S.B., Sadighi Akha, A.A., Miller, R.A., Garcia, G.G. Immunology (2006) [Pubmed]
  5. Ammodytoxin A acceptor in bovine brain synaptic membranes. Krizaj, I., Rowan, E.G., Gubensek, F. Toxicon (1995) [Pubmed]
  6. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Berg, E.L., McEvoy, L.M., Berlin, C., Bargatze, R.F., Butcher, E.C. Nature (1993) [Pubmed]
  7. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. Biancone, L., Bowen, M.A., Lim, A., Aruffo, A., Andres, G., Stamenkovic, I. J. Exp. Med. (1996) [Pubmed]
  8. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. Ory, P.A., Clark, M.R., Kwoh, E.E., Clarkson, S.B., Goldstein, I.M. J. Clin. Invest. (1989) [Pubmed]
  9. Structural and biochemical studies of the C-terminal domain of mouse peptide-N-glycanase identify it as a mannose-binding module. Zhou, X., Zhao, G., Truglio, J.J., Wang, L., Li, G., Lennarz, W.J., Schindelin, H. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  10. Ngly1, a mouse gene encoding a deglycosylating enzyme implicated in proteasomal degradation: expression, genomic organization, and chromosomal mapping. Suzuki, T., Kwofie, M.A., Lennarz, W.J. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  11. Identification of proteins that interact with mammalian peptide:N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradation. Park, H., Suzuki, T., Lennarz, W.J. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  12. Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Toyoshima, M., Nakajima, M., Yamori, T., Tsuruo, T. Cancer Res. (1995) [Pubmed]
  13. Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover. Misaghi, S., Pacold, M.E., Blom, D., Ploegh, H.L., Korbel, G.A. Chem. Biol. (2004) [Pubmed]
  14. High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells. Whittaker, J., Okamoto, A.K., Thys, R., Bell, G.I., Steiner, D.F., Hofmann, C.A. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  15. Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules. Amin, A.R., Tamma, S.M., Oppenheim, J.D., Finkelman, F.D., Kieda, C., Coico, R.F., Thorbecke, G.J. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  16. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. Jaffe, C.L., Rachamim, N., Sarfstein, R. J. Immunol. (1990) [Pubmed]
  17. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. Uemura, K., Yokota, Y., Kozutsumi, Y., Kawasaki, T. J. Biol. Chem. (1996) [Pubmed]
  18. Carbohydrate-binding property of peptide: N-glycanase from mouse fibroblast L-929 cells as evaluated by inhibition and binding experiments using various oligosaccharides. Suzuki, T., Kitajima, K., Inoue, Y., Inoue, S. J. Biol. Chem. (1995) [Pubmed]
  19. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. Sheehan, K.C., Ruddle, N.H., Schreiber, R.D. J. Immunol. (1989) [Pubmed]
  20. Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling. Kusui, T., Benya, R.V., Battey, J.F., Jensen, R.T. Biochemistry (1994) [Pubmed]
  21. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides. Liu-Chen, L.Y., Chen, C., Phillips, C.A. Mol. Pharmacol. (1993) [Pubmed]
  22. Differential susceptibility to N-glycanase at the individual glycosylation sites of mouse thyrotropin and free alpha-subunits. Miura, Y., Perkel, V.S., Magner, J.A. Endocrinology (1988) [Pubmed]
  23. Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype). Grigera, P.R., Mathieu, M.E., Wagner, R.R. Virology (1991) [Pubmed]
  24. Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages. Maruiwa, M., Mizoguchi, A., Russell, G.J., Narula, N., Stronska, M., Mizoguchi, E., Rabb, H., Arnaout, M.A., Bhan, A.K. J. Immunol. (1993) [Pubmed]
  25. A monoclonal antibody against a novel 20-kDa protein induces cell adhesion and cytoskeleton-dependent morphologic changes. Lin, S.L., Derr, D., Hildreth, J.E. J. Immunol. (1992) [Pubmed]
  26. Glycosylation and antigenic variation among Kunjin virus isolates. Adams, S.C., Broom, A.K., Sammels, L.M., Hartnett, A.C., Howard, M.J., Coelen, R.J., Mackenzie, J.S., Hall, R.A. Virology (1995) [Pubmed]
  27. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Raju, T.S., Briggs, J.B., Borge, S.M., Jones, A.J. Glycobiology (2000) [Pubmed]
WikiGenes - Universities